首页> 外文期刊>MBio >NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target
【24h】

NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target

机译:NIRA是来自<命名含量含量 - 型=“属型”>假单胞菌铜绿假单胞菌的替代亚硝酸盐还原酶,其潜在作为抗病毒目标

获取原文
           

摘要

The emergence of widespread antimicrobial resistance has led to the need for development of novel therapeutic interventions. Antivirulence strategies are an attractive alternative to classic antimicrobial therapy; however, they require identification of new specific targets which can be exploited in drug discovery programs. ABSTRACT The opportunistic pathogen Pseudomonas aeruginosa produces an arsenal of virulence factors causing a wide range of diseases in multiple hosts and is difficult to eradicate due to its intrinsic resistance to antibiotics. With the antibacterial pipeline drying up, antivirulence therapy has become an attractive alternative strategy to the traditional use of antibiotics to treat P. aeruginosa infections. To identify P. aeruginosa genes required for virulence in multiple hosts, a random library of Tn 5 mutants in strain PAO1-L was previously screened in vitro for those showing pleiotropic effects in the production of virulence phenotypes. Using this strategy, we identified a Tn 5 mutant with an insertion in PA4130 showing reduced levels of a number of virulence traits in vitro . Construction of an isogenic mutant in this gene presented results similar to those for the Tn 5 mutant. Furthermore, the PA4130 isogenic mutant showed substantial attenuation in disease models of Drosophila melanogaster and Caenorhabditis elegans as well as reduced toxicity in human cell lines. Mice infected with this mutant demonstrated an 80% increased survival rate in acute and agar bead lung infection models. PA4130 codes for a protein with homology to nitrite and sulfite reductases. Overexpression of PA4130 in the presence of the siroheme synthase CysG enabled its purification as a soluble protein. Methyl viologen oxidation assays with purified PA4130 showed that this enzyme is a nitrite reductase operating in a ferredoxin-dependent manner. The preference for nitrite and production of ammonium revealed that PA4130 is an ammonia:ferredoxin nitrite reductase and hence was named NirA.
机译:普遍抗菌抗性抗性的出现导致了新型治疗干预措施的发展。抗病毒策略是经典抗微生物治疗的有吸引力的替代品;但是,它们需要识别可以在药物发现计划中开发的新特定目标。摘要机会主义病原体假单胞菌铜绿假单胞菌产生了一种毒力因子的阿森纳,导致多个宿主中的广泛疾病,并且由于其对抗生素的内在抗性而难以消除。随着抗菌管道干燥,抗病毒治疗已成为传统使用抗生素治疗P.铜绿假单胞菌感染的有吸引力的替代策略。为了鉴定多个宿主中毒力所需的P.铜绿假单胞菌基因,在体外筛选菌株PAO1-L中的TN 5突变体的随机文库,用于显示在毒力表型的产生中的抗血液效应。使用该策略,我们鉴定了PA4130中的插入的TN 5突变体,显示出在体外减少多种毒力性状的水平。在该基因中构建中源性突变体的呈现与TN 5突变体的结果类似。此外,PA4130中源性突变体显示出在果蝇黑素体和Caenorhabdise秀丽隐杆线虫的疾病模型中的显着衰减,以及人类细胞系中的毒性降低。感染这种突变体的小鼠证明了急性和琼脂珠肺感染模型中的80%增加的存活率。 PA4130蛋白质与亚硝酸盐和亚硫酸盐还原酶具有同源性的蛋白质。 Siroheme合酶Cysg存在下PA4130的过度表达使其纯化为可溶性蛋白质。纯化PA4130的甲基Viologen氧化测定显示该酶是以依赖于富铁素依赖性方式操作的亚硝酸盐还原蛋白。对亚硝酸盐和铵生产的偏好显示PA4130是氨:亚硝酸丁石还原酶,因此被命名为Nira。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号